Toronto-based Intellipharmaceutics is a pioneering company in the global pharmaceutical industry, having been established in 1998. A key aspect of Intellipharmaceutics' offerings is its proprietary Hypermatrix™ technology, which serves as a versatile and proven multidimensional controlled-release drug delivery platform. This innovation supports the development of a wide variety of pharmaceutical products, including those already on the market as well as new drug types. Intellipharmaceutics' pipeline comprises generic and new drugs spanning multiple therapeutic categories.
IntelliPharmaCeutics International Inc.'s ticker is IPCI
The company's shares trade on the TSX stock exchange
They are based in Etobicoke, Toronto
There are 51-200 employees working at IntelliPharmaCeutics International Inc.
It is https://www.intellipharmaceutics.com/
IntelliPharmaCeutics International Inc. is in the Healthcare sector
IntelliPharmaCeutics International Inc. is in the Biotechnology industry
The following five companies are IntelliPharmaCeutics International Inc.'s industry peers: